Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
Moazzam Shahzad, Assistant Professor at University of South Florida and Moffitt Cancer Center, shared a post on X about a recent article he and his colleague co-authored, published in Transplantation and Cellular Therapy, adding:
“Our latest article in Transplantation and Cellular Therapy Journal shows Haplo-HCT with PTCy delivers outcomes comparable to MSD-HCT, supporting its use as a robust alternative when a matched sibling donor is unavailable.”
Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, Board Member of Kansas Society of Clinical Oncology, shared Moazzam Shahzad‘s post on X:
“I’ve said it before, and I’ll say it again:
Muhammad Umair Mushtaq and Moazzam Shahzad could build an entire cancer center and run all its clinical trials by themselves!
These two are unstoppable machines!”
Title: Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani, Hediyeh Alemi, Naghmeh Khavandgar, Shah Rukh, Khalid Halahleh, Anurag K. Singh, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Stay updated on all scientific advnaces with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series